Australia medical marijuana trials: global supply shortage forces mums, dads into crime

Warning message

The subscription service is currently unavailable. Please try again later.

Advocates say people with epilepsy in Western Australia are the victims of a frustrating Catch-22 situation, forcing many to break the law to access a drug that has been shown to help control seizures.

Bureaucratic approvals have been given for a trial of medical marijuana, but it's proving impossible to locate a reliable supplier of cannabis oil, the critical plant extract.

The Therapeutic Goods Administration has not yet approved any products, both on a local and imported basis.

This supply situation was highlighted in the experience of Perth mum, Amalia, who told Radio 6PR on Tuesday that WA Health Minister Kim Hames had written to her explaining the impasse.

Amalia's 10-year-old daughter suffers from a rare and severe form of epilepsy known as Dravet Syndrome and has been hospitalised since Saturday night after a seizure.

The compound cannabidiol [CBD] is free of the drug component that causes the high.

Chief executive of...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.